Shareholders to receive more from CSL as revenue and earnings surge
Shareholders of the blood products giant CSL (ASX:ASX) are set to benefit as the company increased its revenue and earnings in the year leading up to June 30. On Tuesday, the company unveiled that it had raised its full-year underlying profit by 10%, reaching $2.61 billion USD ($4 billion AUD), attributed to higher sales in […]
Shareholders to receive more from CSL as revenue and earnings surge Read More »